Showing results (1131-1140 of 6,669) with videos related to

Sort By:
Pageof 667
Annals of Hematology|October 21, 2021
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide studyMałgorzata Salamonowicz-Bodzioch, Jowita Frączkiewicz, Krzysztof Czyżewski, et al.
Annals of Hematology|February 12, 2022
Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysisHuifeng Zhou, Junjie Fan, Jie He, et al.
Annals of Hematology|February 2, 2022
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsElisabeth K M Mack, Sören Hartmann, Petra Ross, et al.
Annals of Hematology|September 26, 2018
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 studyNaomi Kawashima, Akimi Akashi, Yasunobu Nagata, et al.
Annals of Hematology|October 6, 2018
Lymphomatoid granulomatosis mimicking cancer and sarcoidosisGrosse Alexandra, Grosse Claudia
Annals of Hematology|June 27, 2018
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survivalEirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, et al.
Annals of Hematology|June 7, 2019
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practiceEmilia Scalzulli, Matteo Molica, Danilo Alunni Fegatelli, et al.
Annals of Hematology|October 12, 2018
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell typeAnahita Nosrati, Ahmad Monabati, Alireza Sadeghipour, et al.
Annals of Hematology|October 13, 2018
Validation of the Marginal Zone Lymphoma International Prognostic IndexJoohyun Hong, Junhun Cho, Young Hye Ko, et al.
Annals of Hematology|April 17, 2019
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphomaJaewon Hyung, Jung Yong Hong, Dok Hyun Yoon, et al.
Pageof 667